3',4'-Dichlorosalicylanilide,
24448-73-5,
N-(3,4-Dichlorophenyl)-2-hydroxybenzamide,
NSC526290,
ACMC-1CFP5,
AC1L70BU,
Oprea1_059460,
Oprea1_452339,
AC1Q792B,
CTK4F3699,
DTXSID60326278,
XWZCOIHEGFREJR-UHFFFAOYSA-N,
ZINC254584,
ANW-25449,
MFCD00020023,
3',4'-Dichloro-2-hydroxybenzanilide,
AKOS000538929,
MCULE-7303907221,
NSC-526290,
KS-0000159C,
BAS 00327105,
ZB009870,
TC-114194,
D1077,
N-(3,4-dichlorophenyl)-2-hydroxy-benzamide,
N1-(3,4-Dichlorophenyl)-2-hydroxybenzamide,
ST50223259,
Benzamide,N-(3,4-dichlorophenyl)-2-hydroxy-,
N-(3,4-Dichloro-phenyl)-2-hydroxy-benzamide,
N-(3,4-Dichlorophenyl)-2-hydroxybenzamide #,
Benzamide, N-(3,4-dichlorophenyl)-2-hydroxy-,
SR-01000389822,
N-(3,4-dichlorophenyl)(2-hydroxyphenyl)carboxamide,
SR-01000389822-1,
I14-93847,
InChI=1/C13H9Cl2NO2/c14-10-6-5-8(7-11(10)15)16-13(18)9-3-1-2-4-12(9)17/h1-7,17H,(H,16,18,
Salicylanilide analog,
CID352402,